Brain tumors are not only treatable but potentially curable with the evolving therapies explains Dr V Naveen Reddy from ...

During a live event, Samuel M. Rubinstein, MD, discussed the outcomes from the KarMMa-3 trial and real-world patients ...

Glioblastoma has been deadly and hard to treat, but researchers say they’ve made progress with bivalent CAR T-cell therapy ...

MUSC research to use he immune system to fight cancer shows it can be done safer, cheaper and better. An SC company pushing ...

"I won't hold my breath, because most of my patients do relapse at some point, but I was really excited about this curve when ...

A multi-institutional study led by the Icahn School of Medicine at Mount Sinai reports one-third of patients with relapsed or ...

Alfred L. Garfall, MD, provided a deep dive into the phase 2 BMT CTN 1902 trial of ide-cel in multiple myeloma after ...

Trump administration health officials assured drugmakers and researchers at a roundtable hosted by the FDA that they want to ...

A growing body of research indicates that plasma exchange therapy may slow biological aging. But do experts actually ...

The field of Cancer Immunity & Immunotherapy is entering an exciting new phase. While Volume I (see here) of this Research Topic highlighted broad ...

Leaders from the world of cell and gene therapy shared their personal stories and policy recommendations in an extraordinary ...

T-cell therapy has shown remarkable clinical efficacy in haematological malignancies, currently representing a well ...